Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)

Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (Other)
Overall Status
Recruiting
CT.gov ID
NCT05328050
Collaborator
(none)
200
1
184
1.1

Study Details

Study Description

Brief Summary

This registry is a observational, single-center study designed to collect clinical data on patients with achondroplasia and hypochondroplasia.

Condition or Disease Intervention/Treatment Phase
  • Other: Registry

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Local Registry for Data Collection of Patients With Achondroplasia / Hypochondroplasia for Epidemiological, Care and Research Studies
Actual Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2031
Anticipated Study Completion Date :
Dec 31, 2036

Arms and Interventions

Arm Intervention/Treatment
Achondroplasia

Other: Registry
observational, data collection

Hypochondroplasia

Other: Registry
observational, data collection

Outcome Measures

Primary Outcome Measures

  1. Registry of Achondroplasia and Hypochondroplasia Patients [10 years]

    Collection of medical information of achondroplasia and hypochndroplasia patients intended for use in future research studies.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Confirmed diagnosis of achondroplasia/hypochondroplasia

  • Patients (and/or Parents legal guardian when required) able to provide informed consent

Exclusion Criteria:
  • Absence of diagnosis of achondroplasia/hypochondroplasia

  • Patients (and/or Parents legal guardian when required) not able to provide informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Milan Italy 20122

Sponsors and Collaborators

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maria Francesca Bedeschi, Principal investigator, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
ClinicalTrials.gov Identifier:
NCT05328050
Other Study ID Numbers:
  • NaturalhistoryAch2021
First Posted:
Apr 14, 2022
Last Update Posted:
Apr 28, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 28, 2022